{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:56:59Z","timestamp":1790776619499,"version":"4.1.0"},"publisher-location":"Cham","reference-count":94,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319425405","type":"print"},{"value":"9783319425429","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-3-319-42542-9_11","type":"book-chapter","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T09:10:41Z","timestamp":1480583441000},"page":"199-217","source":"Crossref","is-referenced-by-count":53,"title":["Obesity Biomarkers, Metabolism and Risk of Cancer: An Epidemiological Perspective"],"prefix":"10.1007","author":[{"given":"Katharina","family":"Nimptsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Pischon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,2]]},"reference":[{"issue":"10","key":"11_CR1","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.jacc.2013.06.027","volume":"62","author":"KA Britton","year":"2013","unstructured":"Britton KA, Massaro JM, Murabito JM, Kreger BE, Hoffmann U, Fox CS (2013) Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. J Am Coll Cardiol 62(10):921\u2013925. doi: 10.1016\/j.jacc.2013.06.027","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"11_CR2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111.067264","volume":"126","author":"JP Despres","year":"2012","unstructured":"Despres JP (2012) Body fat distribution and risk of cardiovascular disease: an update. Circulation 126(10):1301\u20131313. doi: 10.1161\/CIRCULATIONAHA.111.067264","journal-title":"Circulation"},{"issue":"8","key":"11_CR3","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrc1408","volume":"4","author":"EE Calle","year":"2004","unstructured":"Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev 4(8):579\u2013591. doi: 10.1038\/nrc1408","journal-title":"Nat Rev"},{"key":"11_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev.med.080708.082713","volume":"61","author":"DL Roberts","year":"2010","unstructured":"Roberts DL, Dive C, Renehan AG (2010) Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 61:301\u2013316. doi: 10.1146\/annurev.med.080708.082713","journal-title":"Annu Rev Med"},{"key":"11_CR5","doi-asserted-by":"crossref","unstructured":"Davey Smith G, Ebrahim S (2003) \u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32(1):1\u201322","DOI":"10.1093\/ije\/dyg070"},{"issue":"5","key":"11_CR6","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.mcna.2011.06.002","volume":"95","author":"GM Reaven","year":"2011","unstructured":"Reaven GM (2011) Insulin resistance: the link between obesity and cardiovascular disease. Med Clin N Am 95(5):875\u2013892. doi: 10.1016\/j.mcna.2011.06.002","journal-title":"Med Clin N Am"},{"issue":"1","key":"11_CR7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1079\/PNS200070","volume":"60","author":"R Kaaks","year":"2001","unstructured":"Kaaks R, Lukanova A (2001) Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc 60(1):91\u2013106","journal-title":"Proc Nutr Soc"},{"issue":"10","key":"11_CR8","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nri1937","volume":"6","author":"H Tilg","year":"2006","unstructured":"Tilg H, Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6(10):772\u2013783. doi: 10.1038\/nri1937","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"11_CR9","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","volume":"8","author":"M Pollak","year":"2008","unstructured":"Pollak M (2008) Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev 8(12):915\u2013928","journal-title":"Nat Rev"},{"issue":"11 Suppl","key":"11_CR10","doi-asserted-by":"crossref","first-page":"3109S","DOI":"10.1093\/jn\/131.11.3109S","volume":"131","author":"E Giovannucci","year":"2001","unstructured":"Giovannucci E (2001) Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 131(11 Suppl):3109S\u20133120S","journal-title":"J Nutr"},{"issue":"8","key":"11_CR11","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.tem.2006.08.006","volume":"17","author":"AG Renehan","year":"2006","unstructured":"Renehan AG, Frystyk J, Flyvbjerg A (2006) Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab (TEM) 17(8):328\u2013336. doi: 10.1016\/j.tem.2006.08.006","journal-title":"Trends Endocrinol Metab (TEM)"},{"key":"11_CR12","doi-asserted-by":"publisher","unstructured":"Giovannucci E (2003) Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res\u00a0=\u00a0Hormon- und Stoffwechselforschung\u00a0=\u00a0Hormones et metabolisme 35(11\u201312):694\u2013704. doi: 10.1055\/s-2004-814147","DOI":"10.1055\/s-2004-814147"},{"issue":"6","key":"11_CR13","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S1470-2045(10)70095-4","volume":"11","author":"TJ Key","year":"2010","unstructured":"Key TJ, Appleby PN, Reeves GK, Roddam AW (2010) Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11(6):530\u2013542. doi: 10.1016\/S1470-2045(10)70095-4","journal-title":"Lancet Oncol"},{"issue":"1","key":"11_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1677\/ERC-09-0023","volume":"17","author":"JH Fowke","year":"2010","unstructured":"Fowke JH, Matthews CE, Yu H, Cai Q, Cohen S, Buchowski MS, Zheng W, Blot WJ (2010) Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3. Endocr Relat Cancer 17(1):51\u201360. doi: 10.1677\/ERC-09-0023","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"11_CR15","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1677\/ERC-09-0087","volume":"16","author":"P Vigneri","year":"2009","unstructured":"Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R (2009) Diabetes and cancer. Endocr Relat Cancer 16(4):1103\u20131123. doi: 10.1677\/ERC-09-0087","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"11_CR16","first-page":"103","volume":"50","author":"E Ohmura","year":"1990","unstructured":"Ohmura E, Okada M, Onoda N, Kamiya Y, Murakami H, Tsushima T, Shizume K (1990) Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth. Cancer Res 50(1):103\u2013107","journal-title":"Cancer Res"},{"issue":"3","key":"11_CR17","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/JME-12-0259","volume":"50","author":"M Trajkovic-Arsic","year":"2013","unstructured":"Trajkovic-Arsic M, Kalideris E, Siveke JT (2013) The role of insulin and IGF system in pancreatic cancer. J Mol Endocrinol 50(3):R67\u2013R74. doi: 10.1530\/JME-12-0259","journal-title":"J Mol Endocrinol"},{"issue":"22","key":"11_CR18","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1001\/jama.294.22.2872","volume":"294","author":"RZ Stolzenberg-Solomon","year":"2005","unstructured":"Stolzenberg-Solomon RZ, Graubard BI, Chari S, Limburg P, Taylor PR, Virtamo J, Albanes D (2005) Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA 294(22):2872\u20132878. doi: 10.1001\/jama.294.22.2872","journal-title":"JAMA"},{"key":"11_CR19","doi-asserted-by":"publisher","unstructured":"Wolpin BM, Bao Y, Qian ZR, Wu C, Kraft P, Ogino S, Stampfer MJ, Sato K, Ma J, Buring JE, Sesso HD, Lee IM, Gaziano JM, McTiernan A, Phillips LS, Cochrane BB, Pollak MN, Manson JE, Giovannucci EL, Fuchs CS (2013) Hyperglycemia, insulin resistance, impaired pancreatic beta-cell function, and risk of pancreatic cancer. J Natl Cancer Inst 105(14):1027\u20131035. doi: 10.1093\/jnci\/djt123","DOI":"10.1093\/jnci\/djt123"},{"issue":"9","key":"11_CR20","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1158\/1055-9965.EPI-10-0400","volume":"19","author":"JB Douglas","year":"2010","unstructured":"Douglas JB, Silverman DT, Pollak MN, Tao Y, Soliman AS, Stolzenberg-Solomon RZ (2010) Serum IGF-I, IGF-II, IGFBP-3, and IGF-I\/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomark Prev 19(9):2298\u20132306. doi: 10.1158\/1055-9965.EPI-10-0400","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"4","key":"11_CR21","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/ijc.20147","volume":"110","author":"Y Lin","year":"2004","unstructured":"Lin Y, Tamakoshi A, Kikuchi S, Yagyu K, Obata Y, Ishibashi T, Kawamura T, Inaba Y, Kurosawa M, Motohashi Y, Ohno Y (2004) Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death. Int J Cancer 110(4):584\u2013588. doi: 10.1002\/ijc.20147","journal-title":"Int J Cancer"},{"issue":"5","key":"11_CR22","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/bjc.2012.19","volume":"106","author":"S Rohrmann","year":"2012","unstructured":"Rohrmann S, Grote VA, Becker S, Rinaldi S, Tjonneland A, Roswall N, Gronbaek H, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Racine A, Teucher B, Boeing H, Drogan D, Dilis V, Lagiou P, Trichopoulou A, Palli D, Tagliabue G, Tumino R, Vineis P, Mattiello A, Rodriguez L, Duell EJ, Molina-Montes E, Dorronsoro M, Huerta JM, Ardanaz E, Jeurnink S, Peeters PH, Lindkvist B, Johansen D, Sund M, Ye W, Khaw KT, Wareham NJ, Allen NE, Crowe FL, Fedirko V, Jenab M, Michaud DS, Norat T, Riboli E, Bueno-de-Mesquita HB, Kaaks R (2012) Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European prospective investigation into cancer and nutrition. Br J Cancer 106(5):1004\u20131010. doi: 10.1038\/bjc.2012.19","journal-title":"Br J Cancer"},{"issue":"1","key":"11_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/sj.bjc.6603826","volume":"97","author":"BM Wolpin","year":"2007","unstructured":"Wolpin BM, Michaud DS, Giovannucci EL, Schernhammer ES, Stampfer MJ, Manson JE, Cochrane BB, Rohan TE, Ma J, Pollak MN, Fuchs CS (2007) Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts. Br J Cancer 97(1):98\u2013104. doi: 10.1038\/sj.bjc.6603826","journal-title":"Br J Cancer"},{"issue":"2","key":"11_CR24","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/ijc.22697","volume":"121","author":"M Jenab","year":"2007","unstructured":"Jenab M, Riboli E, Cleveland RJ, Norat T, Rinaldi S, Nieters A, Biessy C, Tjonneland A, Olsen A, Overvad K, Gronbaek H, Clavel-Chapelon F, Boutron-Ruault MC, Linseisen J, Boeing H, Pischon T, Trichopoulos D, Oikonomou E, Trichopoulou A, Panico S, Vineis P, Berrino F, Tumino R, Masala G, Peters PH, van Gils CH, Bueno-de-Mesquita HB, Ocke MC, Lund E, Mendez MA, Tormo MJ, Barricarte A, Martinez-Garcia C, Dorronsoro M, Quiros JR, Hallmans G, Palmqvist R, Berglund G, Manjer J, Key T, Allen NE, Bingham S, Khaw KT, Cust A, Kaaks R (2007) Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition. Int J Cancer 121(2):368\u2013376. doi: 10.1002\/ijc.22697","journal-title":"Int J Cancer"},{"issue":"1","key":"11_CR25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/13813450801954451","volume":"114","author":"P Pisani","year":"2008","unstructured":"Pisani P (2008) Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem 114(1):63\u201370","journal-title":"Arch Physiol Biochem"},{"issue":"7","key":"11_CR26","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/ijc.24927","volume":"126","author":"S Rinaldi","year":"2010","unstructured":"Rinaldi S, Cleveland R, Norat T, Biessy C, Rohrmann S, Linseisen J, Boeing H, Pischon T, Panico S, Agnoli C, Palli D, Tumino R, Vineis P, Peeters PH, van Gils CH, Bueno-de-Mesquita BH, Vrieling A, Allen NE, Roddam A, Bingham S, Khaw KT, Manjer J, Borgquist S, Dumeaux V, Torhild Gram I, Lund E, Trichopoulou A, Makrygiannis G, Benetou V, Molina E, Donate Suarez I, Barricarte Gurrea A, Gonzalez CA, Tormo MJ, Altzibar JM, Olsen A, Tjonneland A, Gronbaek H, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Morois S, Slimani N, Boffetta P, Jenab M, Riboli E, Kaaks R (2010) Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer 126(7):1702\u20131715","journal-title":"Int J Cancer"},{"issue":"10","key":"11_CR27","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1158\/1055-9965.EPI-13-0375","volume":"22","author":"TP Ahern","year":"2013","unstructured":"Ahern TP, Hankinson SE, Willett WC, Pollak MN, Eliassen AH, Tamimi RM (2013) Plasma C-peptide, mammographic breast density, and risk of invasive breast cancer. Cancer Epidemiol Biomark Prev 22(10):1786\u20131796. doi: 10.1158\/1055-9965.EPI-13-0375","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"1","key":"11_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/jnci\/djn415","volume":"101","author":"MJ Gunter","year":"2009","unstructured":"Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X, Anderson GL, Kaplan RC, Harris TG, Howard BV, Wylie-Rosett J, Burk RD, Strickler HD (2009) Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 101(1):48\u201360. doi: 10.1093\/jnci\/djn415","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"11_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/bjc.2011.512","volume":"106","author":"GC Kabat","year":"2012","unstructured":"Kabat GC, Kim MY, Strickler HD, Shikany JM, Lane D, Luo J, Ning Y, Gunter MJ, Rohan TE (2012) A longitudinal study of serum insulin and glucose levels in relation to colorectal cancer risk among postmenopausal women. Br J Cancer 106(1):227\u2013232. doi: 10.1038\/bjc.2011.512","journal-title":"Br J Cancer"},{"issue":"1","key":"11_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/ijc.11193","volume":"106","author":"L Keinan-Boker","year":"2003","unstructured":"Keinan-Boker L, Bueno De Mesquita HB, Kaaks R, Van Gils CH, Van Noord PA, Rinaldi S, Riboli E, Seidell JC, Grobbee DE, Peeters PH (2003) Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer. Int J Cancer 106(1):90\u201395. doi: 10.1002\/ijc.11193","journal-title":"Int J Cancer"},{"issue":"4","key":"11_CR31","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1158\/1055-9965.EPI-07-2686","volume":"17","author":"MJ Gunter","year":"2008","unstructured":"Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Manson JE, Li J, Harris TG, Rohan TE, Xue X, Ho GY, Einstein MH, Kaplan RC, Burk RD, Wylie-Rosett J, Pollak MN, Anderson G, Howard BV, Strickler HD (2008) A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer. Cancer Epidemiol Biomark Prev 17(4):921\u2013929. doi: 10.1158\/1055-9965.EPI-07-2686","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"11_CR32","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3892\/mco.2015.516","volume":"3","author":"Q Wang","year":"2015","unstructured":"Wang Q, Bian CE, Peng H, He L, Zhao X (2015) Association of circulating insulin-like growth factor 1 and insulin-like growth factor binding protein 3 with the risk of ovarian cancer: a systematic review and meta-analysis. Mol Clin Oncol 3(3):623\u2013628. doi: 10.3892\/mco.2015.516","journal-title":"Mol Clin Oncol"},{"issue":"18","key":"11_CR33","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/jnci\/djp260","volume":"101","author":"D Albanes","year":"2009","unstructured":"Albanes D, Weinstein SJ, Wright ME, Mannisto S, Limburg PJ, Snyder K, Virtamo J (2009) Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer. J Natl Cancer Inst 101(18):1272\u20131279","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"11_CR34","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1158\/1055-9965.EPI-07-2694","volume":"17","author":"MJ Borugian","year":"2008","unstructured":"Borugian MJ, Spinelli JJ, Sun Z, Kolonel LN, Oakley-Girvan I, Pollak MD, Whittemore AS, Wu AH, Gallagher RP (2008) Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: a prospective multiethnic study. Cancer Epidemiol Biomark Prev 17(1):252\u2013254","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"1","key":"11_CR35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/cncr.20727","volume":"103","author":"C Chen","year":"2005","unstructured":"Chen C, Lewis SK, Voigt L, Fitzpatrick A, Plymate SR, Weiss NS (2005) Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin. Cancer 103(1):76\u201384","journal-title":"Cancer"},{"issue":"2","key":"11_CR36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.urology.2003.09.060","volume":"63","author":"JS Hubbard","year":"2004","unstructured":"Hubbard JS, Rohrmann S, Landis PK, Metter EJ, Muller DC, Andres R, Carter HB, Platz EA (2004) Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging. Urology 63(2):253\u2013258","journal-title":"Urology"},{"issue":"23","key":"11_CR37","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/jnci\/92.23.1910","volume":"92","author":"P Stattin","year":"2000","unstructured":"Stattin P, Bylund A, Rinaldi S, Biessy C, Dechaud H, Stenman UH, Egevad L, Riboli E, Hallmans G, Kaaks R (2000) Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst 92(23):1910\u20131917","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"11_CR38","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1002\/ijc.22587","volume":"120","author":"T Stocks","year":"2007","unstructured":"Stocks T, Lukanova A, Rinaldi S, Biessy C, Dossus L, Lindahl B, Hallmans G, Kaaks R, Stattin P (2007) Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden. Int J Cancer 120(12):2678\u20132686","journal-title":"Int J Cancer"},{"issue":"5","key":"11_CR39","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10552-014-0369-3","volume":"25","author":"GY Lai","year":"2014","unstructured":"Lai GY, Giovannucci EL, Pollak MN, Peskoe SB, Stampfer MJ, Willett WC, Platz EA (2014) Association of C-peptide and leptin with prostate cancer incidence in the health professionals follow-up study. Cancer Causes Control 25(5):625\u2013632. doi: 10.1007\/s10552-014-0369-3","journal-title":"Cancer Causes Control"},{"key":"11_CR40","doi-asserted-by":"crossref","unstructured":"Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter HB, Metter EJ, Chen C, Weiss NS, Fitzpatrick A, Hsing AW, Lacey JV Jr, Helzlsouer K, Rinaldi S, Riboli E, Kaaks R, Janssen JA, Wildhagen MF, Schroder FH, Platz EA, Pollak M, Giovannucci E, Schaefer C, Quesenberry CP Jr, Vogelman JH, Severi G, English DR, Giles GG, Stattin P, Hallmans G, Johansson M, Chan JM, Gann P, Oliver SE, Holly JM, Donovan J, Meyer F, Bairati I, Galan P (2008) Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med 149(7):461\u2013471, W483\u2013W468","DOI":"10.7326\/0003-4819-149-7-200810070-00006"},{"issue":"3","key":"11_CR41","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/hep.27016","volume":"60","author":"K Aleksandrova","year":"2014","unstructured":"Aleksandrova K, Boeing H, Nothlings U, Jenab M, Fedirko V, Kaaks R, Lukanova A, Trichopoulou A, Trichopoulos D, Boffetta P, Trepo E, Westhpal S, Duarte-Salles T, Stepien M, Overvad K, Tjonneland A, Halkjaer J, Boutron-Ruault MC, Dossus L, Racine A, Lagiou P, Bamia C, Benetou V, Agnoli C, Palli D, Panico S, Tumino R, Vineis P, Bueno-de-Mesquita B, Peeters PH, Gram IT, Lund E, Weiderpass E, Quiros JR, Agudo A, Sanchez MJ, Gavrila D, Barricarte A, Dorronsoro M, Ohlsson B, Lindkvist B, Johansson A, Sund M, Khaw KT, Wareham N, Travis RC, Riboli E, Pischon T (2014) Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer. Hepatology 60(3):858\u2013871. doi: 10.1002\/hep.27016","journal-title":"Hepatology"},{"key":"11_CR42","doi-asserted-by":"publisher","unstructured":"Nead KT, Sharp SJ, Thompson DJ, Painter JN, Savage DB, Semple RK, Barker A, Perry JR, Attia J, Dunning AM, Easton DF, Holliday E, Lotta LA, O\u2019Mara T, McEvoy M, Pharoah PD, Scott RJ, Spurdle AB, Langenberg C, Wareham NJ, Scott RA (2015) Evidence of a causal association between insulinemia and endometrial cancer: a mendelian randomization analysis. J Natl Cancer Inst 107(9). doi: 10.1093\/jnci\/djv178","DOI":"10.1093\/jnci\/djv178"},{"issue":"3","key":"11_CR43","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ijc.11529","volume":"108","author":"A Lukanova","year":"2004","unstructured":"Lukanova A, Lundin E, Micheli A, Arslan A, Ferrari P, Rinaldi S, Krogh V, Lenner P, Shore RE, Biessy C, Muti P, Riboli E, Koenig KL, Levitz M, Stattin P, Berrino F, Hallmans G, Kaaks R, Toniolo P, Zeleniuch-Jacquotte A (2004) Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer 108(3):425\u2013432. doi: 10.1002\/ijc.11529","journal-title":"Int J Cancer"},{"issue":"4","key":"11_CR44","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1677\/erc.1.01038","volume":"12","author":"R Kaaks","year":"2005","unstructured":"Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, Dossus L, Lukanova A, Bingham S, Khaw KT, Allen NE, Bueno-de-Mesquita HB, van Gils CH, Grobbee D, Boeing H, Lahmann PH, Nagel G, Chang-Claude J, Clavel-Chapelon F, Fournier A, Thiebaut A, Gonzalez CA, Quiros JR, Tormo MJ, Ardanaz E, Amiano P, Krogh V, Palli D, Panico S, Tumino R, Vineis P, Trichopoulou A, Kalapothaki V, Trichopoulos D, Ferrari P, Norat T, Saracci R, Riboli E (2005) Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 12(4):1071\u20131082. doi: 10.1677\/erc.1.01038","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"11_CR45","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","volume":"94","author":"T Key","year":"2002","unstructured":"Key T, Appleby P, Barnes I, Reeves G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94(8):606\u2013616","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"11_CR46","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1210\/endo.137.3.8603578","volume":"137","author":"D Kleinman","year":"1996","unstructured":"Kleinman D, Karas M, Danilenko M, Arbell A, Roberts CT, LeRoith D, Levy J, Sharoni Y (1996) Stimulation of endometrial cancer cell growth by tamoxifen is associated with increased insulin-like growth factor (IGF)-I induced tyrosine phosphorylation and reduction in IGF binding proteins. Endocrinology 137(3):1089\u20131095. doi: 10.1210\/endo.137.3.8603578","journal-title":"Endocrinology"},{"issue":"12","key":"11_CR47","first-page":"1531","volume":"11","author":"R Kaaks","year":"2002","unstructured":"Kaaks R, Lukanova A, Kurzer MS (2002) Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomark Prev 11(12):1531\u20131543","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"2","key":"11_CR48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/1464727002000198781","volume":"3","author":"S Wild","year":"2000","unstructured":"Wild S, Pierpoint T, Jacobs H, McKeigue P (2000) Long-term consequences of polycystic ovary syndrome: results of a 31\u00a0year follow-up study. Hum Fertil (Camb) 3(2):101\u2013105","journal-title":"Hum Fertil (Camb)"},{"issue":"3","key":"11_CR49","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djm323","volume":"100","author":"AW Roddam","year":"2008","unstructured":"Roddam AW, Allen NE, Appleby P, Key TJ (2008) Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst 100(3):170\u2013183","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"11_CR50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1158\/1055-9965.EPI-06-0755","volume":"16","author":"S Rinaldi","year":"2007","unstructured":"Rinaldi S, Dossus L, Lukanova A, Peeters PH, Allen NE, Key T, Bingham S, Khaw KT, Trichopoulos D, Trichopoulou A, Oikonomou E, Pera G, Larranaga N, Martinez-Garcia C, Ardanaz E, Quiros JR, Tormo MJ, Tjonneland A, Olsen A, Overvad K, Chang-Claude J, Linseisen J, Schulz M, Boeing H, van Gils CH, Bueno-de-Mesquita BH, Pala V, Palli D, Panico S, Tumino R, Vineis P, Clavel-Chapelon F, Mesrine S, Boutron-Ruault MC, Lundin E, Agren A, Berglund G, Manjer J, Kumle M, Lund E, Slimani N, Saracci R, Riboli E, Kaaks R (2007) Endogenous androgens and risk of epithelial ovarian cancer: results from the European prospective investigation into cancer and nutrition (EPIC). Cancer Epidemiol Biomark Prev 16(1):23\u201329. doi: 10.1158\/1055-9965.EPI-06-0755","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"5","key":"11_CR51","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/ijc.10990","volume":"104","author":"A Lukanova","year":"2003","unstructured":"Lukanova A, Lundin E, Akhmedkhanov A, Micheli A, Rinaldi S, Zeleniuch-Jacquotte A, Lenner P, Muti P, Biessy C, Krogh V, Berrino F, Hallmans G, Riboli E, Kaaks R, Toniolo P (2003) Circulating levels of sex steroid hormones and risk of ovarian cancer. Int J Cancer 104(5):636\u2013642. doi: 10.1002\/ijc.10990","journal-title":"Int J Cancer"},{"key":"11_CR52","doi-asserted-by":"crossref","unstructured":"Chandran M, Phillips SA, Ciaraldi T, Henry RR (2003) Adiponectin: more than just another fat cell hormone? Diabetes Care 26(8):2442\u20132450","DOI":"10.2337\/diacare.26.8.2442"},{"issue":"6","key":"11_CR53","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.2337\/diabetes.51.6.1884","volume":"51","author":"N Stefan","year":"2002","unstructured":"Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, Youngren JF, Havel PJ, Pratley RE, Bogardus C, Tataranni PA (2002) Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 51(6):1884\u20131888","journal-title":"Diabetes"},{"issue":"7","key":"11_CR54","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1210\/me.2009-0498","volume":"24","author":"AY Kim","year":"2010","unstructured":"Kim AY, Lee YS, Kim KH, Lee JH, Lee HK, Jang SH, Kim SE, Lee GY, Lee JW, Jung SA, Chung HY, Jeong S, Kim JB (2010) Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation. Mol Endocrinol 24(7):1441\u20131452. doi: 10.1210\/me.2009-0498","journal-title":"Mol Endocrinol"},{"issue":"6","key":"11_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/carcin\/bgs133","volume":"33","author":"K Aleksandrova","year":"2012","unstructured":"Aleksandrova K, Boeing H, Jenab M, Bueno-de-Mesquita HB, Jansen E, van Duijnhoven FJ, Fedirko V, Rinaldi S, Romieu I, Riboli E, Romaguera D, Westphal S, Overvad K, Tjonneland A, Boutron-Ruault MC, Clavel-Chapelon F, Kaaks R, Lukanova A, Trichopoulou A, Lagiou P, Trichopoulos D, Agnoli C, Mattiello A, Saieva C, Vineis P, Tumino R, Peeters PH, Arguelles M, Bonet C, Sanchez MJ, Dorronsoro M, Huerta JM, Barricarte A, Palmqvist R, Hallmans G, Khaw KT, Wareham N, Allen NE, Crowe FL, Pischon T (2012) Total and high-molecular weight adiponectin and risk of colorectal cancer: the European prospective investigation into cancer and nutrition study. Carcinogenesis 33(6):1\u20138. doi: 10.1093\/carcin\/bgs133","journal-title":"Carcinogenesis"},{"key":"11_CR56","doi-asserted-by":"publisher","unstructured":"Song M, Zhang X, Wu K, Ogino S, Fuchs CS, Giovannucci EL, Chan AT (2013) Plasma adiponectin and soluble leptin receptor and risk of colorectal cancer: a prospective study. Cancer Prev Res 6(9):875\u2013885. doi: 10.1158\/1940-6207.CAPR-13-0169","DOI":"10.1158\/1940-6207.CAPR-13-0169"},{"issue":"4","key":"11_CR57","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1751-2980.2011.00504.x","volume":"12","author":"XT Xu","year":"2011","unstructured":"Xu XT, Xu Q, Tong JL, Zhu MM, Huang ML, Ran ZH, Xiao SD (2011) Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma. J Dig Dis 12(4):234\u2013244. doi: 10.1111\/j.1751-2980.2011.00504.x","journal-title":"J Dig Dis"},{"key":"11_CR58","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.12659\/MSM.893472","volume":"21","author":"X Yang","year":"2015","unstructured":"Yang X, Li J, Cai W, Yang Q, Lu Z, Yu J, Yu H, Zhang N, Sun D, Qu Y, Guo H, Wen F, Ji Y (2015) Adiponectin gene polymorphisms are associated with increased risk of colorectal cancer. Med Sci Monit Int Med J Exp Clin Res 21:2595\u20132606. doi: 10.12659\/MSM.893472","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"key":"11_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29360","author":"M Song","year":"2014","unstructured":"Song M, Gong J, Giovannucci EL, Berndt SI, Brenner H, Chang-Claude J, Curtis KR, Harrison TA, Hoffmeister M, Hsu L, Jiao S, Le Marchand L, Potter JD, Schoen RE, Seminara D, Slattery ML, White E, Wu K, Ogino S, Fuchs CS, Hunter DJ, Tworoger SS, Hu FB, Rimm E, Jensen M, Peters U, Chan AT (2014) Genetic variants of adiponectin and risk of colorectal cancer. Int J Cancer. doi: 10.1002\/ijc.29360","journal-title":"Int J Cancer"},{"key":"11_CR60","doi-asserted-by":"publisher","unstructured":"Gunter MJ, Wang T, Cushman M, Xue X, Wassertheil-Smoller S, Strickler HD, Rohan TE, Manson JE, McTiernan A, Kaplan RC, Scherer PE, Chlebowski RT, Snetselaar L, Wang D, Ho GY (2015) Circulating adipokines and inflammatory markers and postmenopausal breast cancer risk. J Natl Cancer Inst 107(9). doi: 10.1093\/jnci\/djv169","DOI":"10.1093\/jnci\/djv169"},{"issue":"1","key":"11_CR61","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/carcin\/bgs322","volume":"34","author":"LM Liao","year":"2013","unstructured":"Liao LM, Weinstein SJ, Pollak M, Li Z, Virtamo J, Albanes D, Chow WH, Purdue MP (2013) Prediagnostic circulating adipokine concentrations and risk of renal cell carcinoma in male smokers. Carcinogenesis 34(1):109\u2013112. doi: 10.1093\/carcin\/bgs322","journal-title":"Carcinogenesis"},{"key":"11_CR62","doi-asserted-by":"publisher","unstructured":"Soliman PT, Cui X, Zhang Q, Hankinson SE, Lu KH (2011) Circulating adiponectin levels and risk of endometrial cancer: the prospective Nurses\u2019 Health Study. Am J Obstet Gynecol 204(2):167 e161\u2013165. doi: 10.1016\/j.ajog.2010.08.045","DOI":"10.1016\/j.ajog.2010.08.045"},{"key":"11_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27016","author":"K Aleksandrova","year":"2014","unstructured":"Aleksandrova K, Boeing H, Nothlings U, Jenab M, Fedirko V, Kaaks R, Lukanova A, Trichopoulou A, Trichopoulos D, Boffetta P, Trepo E, Westhpal S, Duarte-Salles T, Stepien M, Overvad K, Tjonneland A, Halkjaer J, Boutron-Ruault MC, Dossus L, Racine A, Lagiou P, Bamia C, Benetou V, Agnoli C, Palli D, Panico S, Tumino R, Vineis P, Bueno-de-Mesquita B, Peeters PH, Gram IT, Lund E, Weiderpass E, Quiros JR, Agudo A, Sanchez MJ, Gavrila D, Barricarte A, Dorronsoro M, Ohlsson B, Lindkvist B, Johansson A, Sund M, Khaw KT, Wareham N, Travis RC, Riboli E, Pischon T (2014) Inflammatory and metabolic biomarkers and risk of liver and bilary tract cancer. Hepatology. doi: 10.1002\/hep.27016","journal-title":"Hepatology"},{"issue":"12","key":"11_CR64","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1158\/1055-9965.EPI-13-0363","volume":"22","author":"T Michikawa","year":"2013","unstructured":"Michikawa T, Inoue M, Sawada N, Sasazuki S, Tanaka Y, Iwasaki M, Shimazu T, Yamaji T, Mizokami M, Tsugane S (2013) Plasma levels of adiponectin and primary liver cancer risk in middle-aged Japanese adults with hepatitis virus infection: a nested case-control study. Cancer Epidemiol Biomark Prev 22(12):2250\u20132257. doi: 10.1158\/1055-9965.EPI-13-0363","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"5","key":"11_CR65","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jhep.2010.04.035","volume":"53","author":"G Nkontchou","year":"2010","unstructured":"Nkontchou G, Bastard JP, Ziol M, Aout M, Cosson E, Ganne-Carrie N, Grando-Lemaire V, Roulot D, Capeau J, Trinchet JC, Vicaut E, Beaugrand M (2010) Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis. J Hepatol 53(5):827\u2013833. doi: 10.1016\/j.jhep.2010.04.035","journal-title":"J Hepatol"},{"key":"11_CR66","volume-title":"Chapter 3: leptin and obesity. Leptin","year":"2006","unstructured":"Bell L, Considine R (eds) (2006) Chapter 3: leptin and obesity. Leptin. Springer, New York"},{"issue":"3","key":"11_CR67","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/ncpgasthep0743","volume":"4","author":"ML Slattery","year":"2007","unstructured":"Slattery ML, Wolff RK (2007) Leptin and colorectal cancer: an undefined link. Nat Clin Pract Gastroenterol Hepatol 4(3):118\u2013119. doi: 10.1038\/ncpgasthep0743","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"6505","key":"11_CR68","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","volume":"372","author":"Y Zhang","year":"1994","unstructured":"Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372(6505):425\u2013432","journal-title":"Nature"},{"issue":"1","key":"11_CR69","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/jcp.20472","volume":"207","author":"C Garofalo","year":"2006","unstructured":"Garofalo C, Surmacz E (2006) Leptin and cancer. J Cell Physiol 207(1):12\u201322. doi: 10.1002\/jcp.20472","journal-title":"J Cell Physiol"},{"issue":"1","key":"11_CR70","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1053\/gast.2001.25490","volume":"121","author":"JC Hardwick","year":"2001","unstructured":"Hardwick JC, Van Den Brink GR, Offerhaus GJ, Van Deventer SJ, Peppelenbosch MP (2001) Leptin is a growth factor for colonic epithelial cells. Gastroenterology 121(1):79\u201390","journal-title":"Gastroenterology"},{"issue":"6","key":"11_CR71","first-page":"2015","volume":"10","author":"P Stattin","year":"2003","unstructured":"Stattin P, Palmqvist R, Soderberg S, Biessy C, Ardnor B, Hallmans G, Kaaks R, Olsson T (2003) Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden. Oncol Rep 10(6):2015\u20132021","journal-title":"Oncol Rep"},{"key":"11_CR72","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-0465","author":"K Aleksandrova","year":"2012","unstructured":"Aleksandrova K, Boeing H, Jenab M, Bueno-de-Mesquita HB, Jansen E, van Duijnhoven FJ, Rinaldi S, Fedirko V, Romieu I, Riboli E, Gunter MJ, Westphal S, Overvad K, Tjonneland A, Halkjaer J, Racine A, Boutron-Ruault MC, Clavel-Chapelon F, Kaaks R, Lukanova A, Trichopoulou A, Lagiou P, Trichopoulos D, Mattiello A, Pala V, Palli D, Tumino R, Vineis P, Buckland G, Sanchez MJ, Amiano P, Huerta JM, Barricarte A, Menendez V, Peeters PH, Soderberg S, Palmqvist R, Allen NE, Crowe FL, Khaw KT, Wareham N, Pischon T (2012) Leptin and soluble leptin receptor in risk of colorectal cancer in the European prospective investigation into cancer and nutrition cohort. Cancer Res. doi: 10.1158\/0008-5472.CAN-12-0465","journal-title":"Cancer Res"},{"key":"11_CR73","doi-asserted-by":"publisher","unstructured":"Stattin P, Lukanova A, Biessy C, Soderberg S, Palmqvist R, Kaaks R, Olsson T, Jellum E (2004) Obesity and colon cancer: does leptin provide a link? Int J Cancer 109(1):149\u2013152. doi: 10.1002\/ijc.11668","DOI":"10.1002\/ijc.11668"},{"issue":"4\u20136","key":"11_CR74","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1159\/000086988","volume":"68","author":"K Tamakoshi","year":"2005","unstructured":"Tamakoshi K, Toyoshima H, Wakai K, Kojima M, Suzuki K, Watanabe Y, Hayakawa N, Yatsuya H, Kondo T, Tokudome S, Hashimoto S, Suzuki S, Kawado M, Ozasa K, Ito Y, Tamakoshi A (2005) Leptin is associated with an increased female colorectal cancer risk: a nested case-control study in Japan. Oncology 68(4\u20136):454\u2013461","journal-title":"Oncology"},{"issue":"12","key":"11_CR75","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1158\/0008-5472.CAN-11-2771","volume":"72","author":"GY Ho","year":"2012","unstructured":"Ho GY, Wang T, Gunter MJ, Strickler HD, Cushman M, Kaplan RC, Wassertheil-Smoller S, Xue X, Rajpathak SN, Chlebowski RT, Vitolins MZ, Scherer PE, Rohan TE (2012) Adipokines linking obesity with colorectal cancer risk in postmenopausal women. Cancer Res 72(12):3029\u20133037. doi: 10.1158\/0008-5472.CAN-11-2771","journal-title":"Cancer Res"},{"issue":"24","key":"11_CR76","doi-asserted-by":"publisher","first-page":"7941","DOI":"10.3748\/wjg.v20.i24.7941","volume":"20","author":"RK Joshi","year":"2014","unstructured":"Joshi RK, Kim WJ, Lee SA (2014) Association between obesity-related adipokines and colorectal cancer: a case-control study and meta-analysis. World J Gastroenterol (WJG) 20(24):7941\u20137949. doi: 10.3748\/wjg.v20.i24.7941","journal-title":"World J Gastroenterol (WJG)"},{"key":"11_CR77","doi-asserted-by":"publisher","unstructured":"Partida-Perez M, de la Luz Ayala-Madrigal M, Peregrina-Sandoval J, Macias-Gomez N, Moreno-Ortiz J, Leal-Ugarte E, Cardenas-Meza M, Centeno-Flores M, Maciel-Gutierrez V, Cabrales E, Cervantes-Ortiz S, Gutierrez-Angulo M (2010) Association of LEP and ADIPOQ common variants with colorectal cancer in Mexican patients. Cancer Biomark (section A of Disease markers) 7(3):117\u2013121. doi: 10.3233\/CBM-2010-0154","DOI":"10.3233\/CBM-2010-0154"},{"key":"11_CR78","doi-asserted-by":"publisher","unstructured":"Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539\u2013545. doi: 10.1016\/S0140-6736(00)04046-0","DOI":"10.1016\/S0140-6736(00)04046-0"},{"issue":"6","key":"11_CR79","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.cgh.2012.01.010","volume":"10","author":"T Jess","year":"2012","unstructured":"Jess T, Rungoe C, Peyrin-Biroulet L (2012) Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol (The Official Clinical Practice Journal of the American Gastroenterological Association) 10(6):639\u2013645. doi: 10.1016\/j.cgh.2012.01.010","journal-title":"Clin Gastroenterol Hepatol (The Official Clinical Practice Journal of the American Gastroenterological Association)"},{"issue":"4","key":"11_CR80","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s11605-010-1402-9","volume":"15","author":"MG Laukoetter","year":"2011","unstructured":"Laukoetter MG, Mennigen R, Hannig CM, Osada N, Rijcken E, Vowinkel T, Krieglstein CF, Senninger N, Anthoni C, Bruewer M (2011) Intestinal cancer risk in Crohn\u2019s disease: a meta-analysis. J Gastrointest Surg (Official Journal of the Society for Surgery of the Alimentary Tract) 15(4):576\u2013583. doi: 10.1007\/s11605-010-1402-9","journal-title":"J Gastrointest Surg (Official Journal of the Society for Surgery of the Alimentary Tract)"},{"issue":"8","key":"11_CR81","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jama.294.8.914","volume":"294","author":"AT Chan","year":"2005","unstructured":"Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS (2005) Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA 294(8):914\u2013923. doi: 10.1001\/jama.294.8.914","journal-title":"JAMA"},{"issue":"1","key":"11_CR82","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1053\/j.gastro.2007.09.035","volume":"134","author":"AT Chan","year":"2008","unstructured":"Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Wu K, Fuchs CS (2008) Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology 134(1):21\u201328. doi: 10.1053\/j.gastro.2007.09.035","journal-title":"Gastroenterology"},{"issue":"21","key":"11_CR83","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1056\/NEJMoa067208","volume":"356","author":"AT Chan","year":"2007","unstructured":"Chan AT, Ogino S, Fuchs CS (2007) Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med 356(21):2131\u20132142. doi: 10.1056\/NEJMoa067208","journal-title":"N Engl J Med"},{"issue":"4","key":"11_CR84","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/jnci\/djn485","volume":"101","author":"BF Cole","year":"2009","unstructured":"Cole BF, Logan RF, Halabi S, Benamouzig R, Sandler RS, Grainge MJ, Chaussade S, Baron JA (2009) Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst 101(4):256\u2013266. doi: 10.1093\/jnci\/djn485","journal-title":"J Natl Cancer Inst"},{"issue":"6917","key":"11_CR85","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860\u2013867. doi: 10.1038\/nature01322","journal-title":"Nature"},{"issue":"2","key":"11_CR86","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3945\/ajcn.110.002683","volume":"93","author":"S Pendyala","year":"2011","unstructured":"Pendyala S, Neff LM, Suarez-Farinas M, Holt PR (2011) Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis. Am J Clin Nutr 93(2):234\u2013242. doi: 10.3945\/ajcn.110.002683","journal-title":"Am J Clin Nutr"},{"key":"11_CR87","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27942","author":"AT Toriola","year":"2012","unstructured":"Toriola AT, Cheng TY, Neuhouser ML, Wener MH, Zheng Y, Brown E, Miller JW, Song X, Beresford SA, Gunter MJ, Caudill MA, Ulrich CM (2012) Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers. Int J Cancer. doi: 10.1002\/ijc.27942","journal-title":"Int J Cancer"},{"key":"11_CR88","doi-asserted-by":"publisher","unstructured":"Toriola AT, Ulrich CM (2011) Is there a potential use for C-reactive protein as a diagnostic and prognostic marker for colorectal cancer? Future Oncol 7(10):1125\u20131128. doi: 10.2217\/fon.11.92","DOI":"10.2217\/fon.11.92"},{"issue":"5","key":"11_CR89","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/ijc.23606","volume":"123","author":"KK Tsilidis","year":"2008","unstructured":"Tsilidis KK, Branchini C, Guallar E, Helzlsouer KJ, Erlinger TP, Platz EA (2008) C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int J Cancer 123(5):1133\u20131140. doi: 10.1002\/ijc.23606","journal-title":"Int J Cancer"},{"issue":"4","key":"11_CR90","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/aje\/kwq135","volume":"172","author":"K Aleksandrova","year":"2010","unstructured":"Aleksandrova K, Jenab M, Boeing H, Jansen E, Bueno-de-Mesquita HB, Rinaldi S, Riboli E, Overvad K, Dahm CC, Olsen A, Tjonneland A, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Palli D, Krogh V, Tumino R, Vineis P, Panico S, Kaaks R, Rohrmann S, Trichopoulou A, Lagiou P, Trichopoulos D, van Duijnhoven FJ, Leufkens AM, Peeters PH, Rodriguez L, Bonet C, Sanchez MJ, Dorronsoro M, Navarro C, Barricarte A, Palmqvist R, Hallmans G, Khaw KT, Wareham N, Allen NE, Spencer E, Romaguera D, Norat T, Pischon T (2010) Circulating C-reactive protein concentrations and risks of colon and rectal cancer: a nested case-control study within the European prospective investigation into cancer and nutrition. Am J Epidemiol 172(4):407\u2013418. doi: 10.1093\/aje\/kwq135","journal-title":"Am J Epidemiol"},{"issue":"5","key":"11_CR91","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/ijc.29086","volume":"136","author":"K Nimptsch","year":"2015","unstructured":"Nimptsch K, Aleksandrova K, Boeing H, Janke J, Lee YA, Jenab M, Bueno-de-Mesquita HB, Jansen EH, Tsilidis KK, Trichopoulou A, Weiderpass E, Wu C, Overvad K, Tjonneland A, Boutron-Ruault MC, Dossus L, Racine A, Kaaks R, Canzian F, Lagiou P, Trichopoulos D, Palli D, Agnoli C, Tumino R, Vineis P, Panico S, Johansson A, Van Guelpen B, Khaw KT, Wareham N, Peeters PH, Quiros JR, Vencesla Garcia A, Molina-Montes E, Dorronsoro M, Chirlaque MD, Barricarte Gurrea A, Key TJ, Duarte-Salles T, Stepien M, Gunter MJ, Riboli E, Pischon T (2015) Association of CRP genetic variants with blood concentrations of C-reactive protein and colorectal cancer risk. Int J Cancer 136(5):1181\u20131192. doi: 10.1002\/ijc.29086","journal-title":"Int J Cancer"},{"issue":"12","key":"11_CR92","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1007\/s10552-013-0285-y","volume":"24","author":"AE Prizment","year":"2013","unstructured":"Prizment AE, Folsom AR, Dreyfus J, Anderson KE, Visvanathan K, Joshu CE, Platz EA, Pankow JS (2013) Plasma C-reactive protein, genetic risk score, and risk of common cancers in the atherosclerosis risk in communities study. Cancer Causes Control 24(12):2077\u20132087. doi: 10.1007\/s10552-013-0285-y","journal-title":"Cancer Causes Control"},{"issue":"3","key":"11_CR93","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/jnci\/djp459","volume":"102","author":"KH Allin","year":"2010","unstructured":"Allin KH, Nordestgaard BG, Zacho J, Tybjaerg-Hansen A, Bojesen SE (2010) C-reactive protein and the risk of cancer: a mendelian randomization study. J Natl Cancer Inst 102(3):202\u2013206. doi: 10.1093\/jnci\/djp459","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"11_CR94","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s10552-015-0641-1","volume":"26","author":"A Kakourou","year":"2015","unstructured":"Kakourou A, Koutsioumpa C, Lopez DS, Hoffman-Bolton J, Bradwin G, Rifai N, Helzlsouer KJ, Platz EA, Tsilidis KK (2015) Interleukin-6 and risk of colorectal cancer: results from the CLUE II cohort and a meta-analysis of prospective studies. Cancer Causes Control 26(10):1449\u20131460. doi: 10.1007\/s10552-015-0641-1","journal-title":"Cancer Causes Control"}],"container-title":["Recent Results in Cancer Research","Obesity and Cancer"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-42542-9_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T22:46:51Z","timestamp":1718923611000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-42542-9_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319425405","9783319425429"],"references-count":94,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-42542-9_11","relation":{},"ISSN":["0080-0015","2197-6767"],"issn-type":[{"value":"0080-0015","type":"print"},{"value":"2197-6767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}